Cargando…

Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study

INTRODUCTION: It is widely recognized that providing healthcare may produce harm to the patient. Different approaches have been developed to measure the burden of adverse events (AEs) to plan and measure the effects of interventions. One of the most widely used instruments is the Trigger Tool, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Kannukene, Angela, Orrego, Carola, Lember, Margus, Uusküla, Anneli, Põlluste, Kaja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019657/
https://www.ncbi.nlm.nih.gov/pubmed/36928658
http://dx.doi.org/10.1371/journal.pone.0280200
_version_ 1784908071138492416
author Kannukene, Angela
Orrego, Carola
Lember, Margus
Uusküla, Anneli
Põlluste, Kaja
author_facet Kannukene, Angela
Orrego, Carola
Lember, Margus
Uusküla, Anneli
Põlluste, Kaja
author_sort Kannukene, Angela
collection PubMed
description INTRODUCTION: It is widely recognized that providing healthcare may produce harm to the patient. Different approaches have been developed to measure the burden of adverse events (AEs) to plan and measure the effects of interventions. One of the most widely used instruments is the Trigger Tool, which has previously been modified to be used on various settings and translated into many languages. Multimorbidity complicates care and may increase the number of AEs patients experience. Currently there is no instrument designed to measure AEs in multimorbid patients. In Estonia, there is currently no validated instrument to measure the burden of AEs. AIMS: The aim of this study will be evaluating the characteristics and ocurrence of AEs in multimorbid patients in hospitalised internal medicine patients of Estonia, and describes the development of a trigger tool for this purpose. METHODS AND ANALYSIS: We will search for the evidence on measuring AEs in the population of multimorbid patients focusing on trigger tools, and synthesize the data. Data collection of the triggers from the literature will be followed by translating triggers from English to Estonian. An expert multidisciplinary panel will select the suitable triggers for this population. Trigger tool will be pre-tested to assess agreement among professionals and usability of the tool. Validation will be done using 90 medical records. A cross-sectional study in internal medicine departments of two Estonian tertiary care hospitals will be performed to identify the frequency and characteristics of AEs in 960 medical records. We will also provide preventability potential and influencing factors. DISSEMINATION: Results will be disseminated to healthcare providers and stakeholders at national and international conferences, and as a doctoral medical thesis.
format Online
Article
Text
id pubmed-10019657
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100196572023-03-17 Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study Kannukene, Angela Orrego, Carola Lember, Margus Uusküla, Anneli Põlluste, Kaja PLoS One Study Protocol INTRODUCTION: It is widely recognized that providing healthcare may produce harm to the patient. Different approaches have been developed to measure the burden of adverse events (AEs) to plan and measure the effects of interventions. One of the most widely used instruments is the Trigger Tool, which has previously been modified to be used on various settings and translated into many languages. Multimorbidity complicates care and may increase the number of AEs patients experience. Currently there is no instrument designed to measure AEs in multimorbid patients. In Estonia, there is currently no validated instrument to measure the burden of AEs. AIMS: The aim of this study will be evaluating the characteristics and ocurrence of AEs in multimorbid patients in hospitalised internal medicine patients of Estonia, and describes the development of a trigger tool for this purpose. METHODS AND ANALYSIS: We will search for the evidence on measuring AEs in the population of multimorbid patients focusing on trigger tools, and synthesize the data. Data collection of the triggers from the literature will be followed by translating triggers from English to Estonian. An expert multidisciplinary panel will select the suitable triggers for this population. Trigger tool will be pre-tested to assess agreement among professionals and usability of the tool. Validation will be done using 90 medical records. A cross-sectional study in internal medicine departments of two Estonian tertiary care hospitals will be performed to identify the frequency and characteristics of AEs in 960 medical records. We will also provide preventability potential and influencing factors. DISSEMINATION: Results will be disseminated to healthcare providers and stakeholders at national and international conferences, and as a doctoral medical thesis. Public Library of Science 2023-03-16 /pmc/articles/PMC10019657/ /pubmed/36928658 http://dx.doi.org/10.1371/journal.pone.0280200 Text en © 2023 Kannukene et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Study Protocol
Kannukene, Angela
Orrego, Carola
Lember, Margus
Uusküla, Anneli
Põlluste, Kaja
Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study
title Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study
title_full Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study
title_fullStr Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study
title_full_unstemmed Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study
title_short Estonian adverse events study for multimorbid patients using Estonian Trigger Tool (MUPETT—MUltimorbid Patients—Estonian Trigger Tool). Development of Estonian trigger tool for multimorbid patients. A study protocol for mixed-methods study
title_sort estonian adverse events study for multimorbid patients using estonian trigger tool (mupett—multimorbid patients—estonian trigger tool). development of estonian trigger tool for multimorbid patients. a study protocol for mixed-methods study
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019657/
https://www.ncbi.nlm.nih.gov/pubmed/36928658
http://dx.doi.org/10.1371/journal.pone.0280200
work_keys_str_mv AT kannukeneangela estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy
AT orregocarola estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy
AT lembermargus estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy
AT uuskulaanneli estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy
AT pollustekaja estonianadverseeventsstudyformultimorbidpatientsusingestoniantriggertoolmupettmultimorbidpatientsestoniantriggertooldevelopmentofestoniantriggertoolformultimorbidpatientsastudyprotocolformixedmethodsstudy